Role of antiretroviral therapies in mucocutaneous manifestations in HIV-infected children over a period of two decades. - Wikidata - awgldk - TriplyDB

Role of antiretroviral therapies in mucocutaneous manifestations in HIV-infected children over a period of two decades.

Role of antiretroviral therapies in mucocutaneous manifestations in HIV-infected children over a period of two decades.

http://www.wikidata.org/entity/Q38472689

about

Perinatally acquired HIV infection in adolescents from sub-Saharan Africa: a review of emerging challenges The pattern of mucocutaneous disorders in HIV-infected children attending care and treatment centres in Dar es Salaam, Tanzania.The pattern of mucocutaneous disorders in HIV infected children attending care and treatment in Tikur Anbesa specialized hospital, Addis Ababa, Ethiopia.Skin disease among human immunodeficiency virus-infected adolescents in Zimbabwe: a strong indicator of underlying HIV infection Temporal trends in mucocutaneous findings among human immunodeficiency virus 1-infected children in a population-based cohort Pediatric HIV immune reconstitution inflammatory syndrome.Causes of morbidity among HIV-infected children on antiretroviral therapy in primary care facilities in Lusaka, Zambia.Mucocutaneous Disorders of Pediatric HIV in South West Nigeria: Surrogates for Immunologic and Virologic Indices.Skin disorders affecting human immunodeficiency virus-infected children living in an orphanage in Ethiopia.

P2860

Q27022471-243B4DDE-F891-4391-96AE-4A0748950906 Q33481970-A070B5ED-E135-4585-8438-F5EFBC0CD2CC Q33592616-6515A77F-02EB-429C-947E-9A97F98E329F Q36193423-AD53B0EC-C706-4864-BFC0-E019D76B4179 Q36612142-ECE8C4D5-11EE-4F3C-8F00-62D48163F372 Q37187414-AC9DCA88-6771-42BB-90EF-A156EF255B92 Q37498812-28B96FB7-62BF-4837-BEC8-5CC2DA8EF94D Q42267776-5509F037-6A4D-4E9D-98A1-8A0C4F296AAF Q45360956-739BC86D-CA42-4A9A-915B-62BA8F43BA44

P2860

Role of antiretroviral therapies in mucocutaneous manifestations in HIV-infected children over a period of two decades.

http://www.wikidata.org/entity/Q38472689

description

2005 nî lūn-bûn

@nan

2005年の論文

@ja

2005年論文

@yue

2005年論文

@zh-hant

2005年論文

@zh-hk

2005年論文

@zh-mo

2005年論文

@zh-tw

2005年论文

@wuu

2005年论文

@zh

2005年论文

@zh-cn

name

Role of antiretroviral therapi ...... over a period of two decades.

@en

type

label

Role of antiretroviral therapi ...... over a period of two decades.

@en

prefLabel

Role of antiretroviral therapi ...... over a period of two decades.

@en

P1433

Q38472689-62CEE268-AB38-484F-834F-E360FDDBF315

P1476

Q38472689-2B640BE6-96BD-4CA8-BC78-03422F8F23A5

P2093

Q38472689-35D849D1-C840-4A57-BDCC-0520322192EA

Q38472689-DADE9BC6-5F3D-4AE4-AE7A-F35383F0795B

P2860

Q38472689-02AD8D9E-012B-4B51-986B-E115E9E3071B

Q38472689-0531BC29-8FC2-43E3-BC14-9DA6BC92D78F

Q38472689-09B73126-F278-4E84-BB0A-132A978D5834

Q38472689-353971DB-EC41-4A5A-8405-202E474CDD3C

Q38472689-3759134D-2B3E-41DE-8B5B-97B83D40C319

Q38472689-490F8277-138F-41E6-A127-A33D07CBDE87

Q38472689-5999B13F-A2F5-4242-90B5-28EBB68007CA

Q38472689-7EA82645-34EE-4DCA-927E-0AAE695A40E6

Q38472689-83CFE538-C64C-4650-A622-3203C1CE4516

Q38472689-9368ECE3-C9AE-4679-B1F9-B4437F4AB2CF

P304

Q38472689-B034DBE9-292A-4436-A719-B4745D42A43D

P31

Q38472689-567F488F-3218-4C90-B593-3061089B6FAD

P356

Q38472689-A8F445DD-C91E-4264-81EB-DFF7D5D34B28

P407

Q38472689-44988E2F-4348-41A0-877D-9DCF144F251C

P433

Q38472689-C39A20A9-13D8-4404-ACE0-DCE7A11C7643

P478

Q38472689-F389CC52-8D76-47D7-BAD3-90D0685089D5

P50

Q38472689-30F99F0A-9484-4248-96B7-4AF1F2B2D7F8

Q38472689-8670CBB4-EA4F-42B4-988F-95F7F032AC38

P577

Q38472689-CE2D41C1-A980-4EDC-B05C-993B38A5E33A

P698

Q38472689-B26A75A6-CAF4-4BA9-BD0B-E86D0F1B5A91

P921

Q38472689-E3174942-AE8F-4BC8-9F38-6AF58E02BFD1

P356

J.1365-2133.2005.06758.X

P1433

British Journal of Dermatology

P1476

Role of antiretroviral therapi ...... n over a period of two decades

@en

P2093

Gurbindo D

http://www.w3.org/2001/XMLSchema#string

Seoane Reula E

http://www.w3.org/2001/XMLSchema#string

P2860

Identification of a major co-receptor for primary isolates of HIV-1

Prognostic factors and survival in children with perinatal HIV-1 infection. The Italian Register for HIV Infections in Children.

Efficacy of highly active antiretroviral therapy in HIV-1 infected children.

Plasma viral load and CD4+ lymphocytes as prognostic markers of HIV-1 infection.

Dermatologic manifestations of human immunodeficiency virus infection.

Impact of antiretroviral protocols on dynamics of AIDS progression markers

Change in coreceptor use correlates with disease progression in HIV-1--infected individuals

Cutaneous manifestations of human immunodeficiency virus infection. Part II.

Viral phenotype affects the thymic production of new T cells in HIV-1-infected children.

Recovery of replication-competent virus from CD4 T cell reservoirs and change in coreceptor use in human immunodeficiency virus type 1-infected children responding to highly active antiretroviral therapy.

P304

382-389

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/J.1365-2133.2005.06758.X

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

153

http://www.w3.org/2001/XMLSchema#string

P50

Mª Ángeles Muñoz-Fernández

P577

2005-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

16086754

http://www.w3.org/2001/XMLSchema#string

P921

antiretroviral drug